Ethicon Endo-Surgery Holds Metabolic Surgery Scientific Forum Featuring Research By Top ...(controlled/poorly controlled diabetes). ...),Health

Dr. Schauer summed up the session with a review of the American Diabetes Association (ADA) 2009 Treatment Guidelines that for the first time said, "bariatric surgery should be considered for adults with BMI >/- 35 kg/m2 and type 2 diabetes, especially if the diabetes is difficult to control with lifestyle and pharmacologic therapy." He pointed out that the ADA Guidelines stated that "bariatric surgery has been shown to lead to near or complete normalization of glycemia in 55-95% of patients with type 2 diabetes, depending on the surgical procedure."

"Diabetes is a chronic progressive disease," said Dr. Schauer. "BMI is easy to measure and a pretty good indication of the percentage of body fat, so we should just use it as a marker but not a rule."

About Ethicon Endo-Surgery

Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology.

Ethicon Endo-Surgery Commitment to Metabolic Surgery

In 2008, Ethicon Endo-Surgery partnered with the University of Cincinnati (UC) through a significant three-year investment to gain a better understanding of the basic biology behind obesity. Ethicon Endo-Surgery engineers and UC researchers will work together to find new solutions for treating obesity and related conditions, including diabetes.

In 2009, the company also signed a three-year research contract with Massachusetts General to deconstruct and understand the how and why
'/>"/>